PURPOSE: Intravenous administration of indocyanine green (ICG) dye can effectively convert near-infrared (NIR) laser light into heat and enhance thermal injury of blood vessels; however, there is no selective uptake of ICG by the tumour compared to the other tissues, which impacts the therapeutic ratio of this strategy unless uptake can be selectively increased in tumour tissue. Here we investigated the use of local hyperthermia prior to intravenous ICG administration to enhance ICG uptake in tumour tissue, thereby enhancing laser thermal ablation of solid tumours. METHODS: Murine SCK breast or SCCVII head and neck tumours were treated with a 755-nm laser light either alone or with prior intravenous administration of 4 mg/kg ICG and/or local tumour hyperthermia at 42.5 °C for 60 min. Retention of ICG was quantified using a NIR animal imaging system. Treatment effects were assessed by growth delay and histology. RESULTS: ICG accumulation in the heated tumours was 1.23-fold greater on average compared to non-heated tumours, in both models. In SCK tumours, animals receiving either laser irradiation alone or in conjunction with ICG had a 1.86- or 3.91-fold increase in tumour growth delay, respectively. The addition of local hyperthermia before ICG injection resulted in complete regression of SCK tumours. Uptake of ICG increased in SCCVII tumours; however, little change in tumour growth delay was observed. CONCLUSION: Using local hyperthermia may improve the delivery of ICG to the tumour and thereby increase the extent of laser thermal ablation of smaller superficial malignancies that can be effectively exposed to laser therapy.
PURPOSE: Intravenous administration of indocyanine green (ICG) dye can effectively convert near-infrared (NIR) laser light into heat and enhance thermal injury of blood vessels; however, there is no selective uptake of ICG by the tumour compared to the other tissues, which impacts the therapeutic ratio of this strategy unless uptake can be selectively increased in tumour tissue. Here we investigated the use of local hyperthermia prior to intravenous ICG administration to enhance ICG uptake in tumour tissue, thereby enhancing laser thermal ablation of solid tumours. METHODS:MurineSCK breast or SCCVII head and neck tumours were treated with a 755-nm laser light either alone or with prior intravenous administration of 4 mg/kg ICG and/or local tumour hyperthermia at 42.5 °C for 60 min. Retention of ICG was quantified using a NIR animal imaging system. Treatment effects were assessed by growth delay and histology. RESULTS:ICG accumulation in the heated tumours was 1.23-fold greater on average compared to non-heated tumours, in both models. In SCK tumours, animals receiving either laser irradiation alone or in conjunction with ICG had a 1.86- or 3.91-fold increase in tumour growth delay, respectively. The addition of local hyperthermia before ICG injection resulted in complete regression of SCK tumours. Uptake of ICG increased in SCCVII tumours; however, little change in tumour growth delay was observed. CONCLUSION: Using local hyperthermia may improve the delivery of ICG to the tumour and thereby increase the extent of laser thermal ablation of smaller superficial malignancies that can be effectively exposed to laser therapy.
Authors: Laura C Kennedy; Lissett R Bickford; Nastassja A Lewinski; Andrew J Coughlin; Ying Hu; Emily S Day; Jennifer L West; Rebekah A Drezek Journal: Small Date: 2010-12-14 Impact factor: 13.281
Authors: Gal Shafirstein; Wolfgang Bäumler; Leah J Hennings; Eric R Siegel; Ran Friedman; Mauricio A Moreno; Jessica Webber; Cassie Jackson; Robert J Griffin Journal: Int J Cancer Date: 2011-07-21 Impact factor: 7.396
Authors: Philipp Babilas; Gal Shafirstein; Jürgen Baier; Vivien Schacht; Rolf-Markus Szeimies; Michael Landthaler; Wolfgang Bäumler; Christoph Abels Journal: Lasers Surg Med Date: 2007-04 Impact factor: 4.025
Authors: Mark E Zafereo; Matthew M Hanasono; David I Rosenthal; Erich M Sturgis; Jan S Lewin; Diana B Roberts; Randal S Weber Journal: Cancer Date: 2009-12-15 Impact factor: 6.860
Authors: Leah Hennings; Yihong Kaufmann; Robert Griffin; Eric Siegel; Petr Novak; Peter Corry; Eduardo G Moros; Gal Shafirstein Journal: Int J Hyperthermia Date: 2009-08 Impact factor: 3.914
Authors: David J Cuccia; Frederic Bevilacqua; Anthony J Durkin; Sean Merritt; Bruce J Tromberg; Gultekin Gulsen; Hon Yu; Jun Wang; Orhan Nalcioglu Journal: Appl Opt Date: 2003-06-01 Impact factor: 1.980
Authors: Derek Reichel; Louis T Curtis; Elizabeth Ehlman; B Mark Evers; Piotr Rychahou; Hermann B Frieboes; Younsoo Bae Journal: Pharm Res Date: 2017-08-24 Impact factor: 4.200
Authors: Samuel John Fahrenholtz; Reza Madankan; Shabbar Danish; John D Hazle; R Jason Stafford; David Fuentes Journal: Int J Hyperthermia Date: 2017-05-19 Impact factor: 3.914
Authors: Yuanyuan Xu; Shan Long; Yunning Yang; Feifan Zhou; Ning Dong; Kesong Yan; Bo Wang; Yachao Zeng; Nan Du; Xiaosong Li; Wei R Chen Journal: Theor Biol Med Model Date: 2019-08-19 Impact factor: 2.432
Authors: Nathan A Koonce; Joseph Levy; Matthew E Hardee; Azemat Jamshidi-Parsian; Kieng B Vang; Sunil Sharma; James A Raleigh; Ruud P M Dings; Robert J Griffin Journal: PLoS One Date: 2015-08-26 Impact factor: 3.240